To Create an Artificial Intelligence-enabled Device for Airway Assessment (AINFAS) to Identify Patients With Difficult Airway Pre-operatively.

February 8, 2026 updated by: National University Hospital, Singapore

Artificial INtelligence eNabled 3D Facial Scanner for Airway Assessment (AINFAS)

We're developing a new AI, which uses advanced computer technology to help doctors identify patients who might have a difficult airway before surgery or emergency procedures. Sometimes, when a person needs help breathing, doctors have to insert a tube into their airway. This can be challenging for some people due to the shape of their mouth, throat, or neck. We hope that AI will look at a patient's facial features to predict if there might be any difficulties.

Study Overview

Status

Active, not recruiting

Conditions

Detailed Description

AINFAS (Artificial Intelligence-enabled system for airway assessment) is an innovative AI system we're developing to revolutionize airway management in healthcare. This advanced artificial intelligence is designed to analyze patient characteristics and predict potential difficulties in airway management before any medical procedure that might require breathing assistance. Using sophisticated machine learning algorithms, AINFAS processes data such as facial structure and neck anatomy to assess the likelihood of a difficult airway. This non-invasive, rapid assessment tool has potential applications across various healthcare settings, including pre-operative assessments, emergency departments, intensive care units, and even pre-hospital care. By providing early identification of potential airway challenges, AINFAS aims to enhance patient safety, improve resource allocation, and provide a standardized, objective method of airway assessment. Currently in development and testing, this AI system represents a significant step forward in using technology to enhance clinical decision-making and patient safety in critical aspects of medical care.

Study Type

Observational

Enrollment (Actual)

1000

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

      • Singapore, Singapore, 119074
        • National University Hospital Singapore

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

  • Adult
  • Older Adult

Accepts Healthy Volunteers

No

Sampling Method

Non-Probability Sample

Study Population

Patients that undergoing surgery in National University Hospital Singapore Only.

Description

Inclusion Criteria:

  • Undergoing surgery under general anaesthesia requiring endotracheal intubation or supraglottic airway
  • 21-100 years old

Exclusion Criteria:

  • Age less than 21 years
  • Patients with prior surgery with altered facial appearance
  • Patients with tracheostomy
  • Patients with any oropharyngeal pathology
  • Patients with nasopharyngeal carcinoma post radiotherapy or chemotherapy
  • Pregnant females
  • Patients whose physicians did not use a laryngoscope or supraglottic airway

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

Cohorts and Interventions

Group / Cohort
Intervention / Treatment
General anaesthesia surgery
participants having their photograph taken using a tablet device following a standardized protocol to capture relevant facial and neck features. These photographs will then be analyzed using software, which assesses the images for potential indicators of a difficult airway.

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Accuracy of AINFAS in Predicting Difficult Airways
Time Frame: Assessment will occur from the time of preoperative AI analysis through to the completion of the intubation procedure, typically within 48 hours.
To identify and characterize the key predictive parameters that contribute to the AI system's overall ability to detect difficult airways.
Assessment will occur from the time of preoperative AI analysis through to the completion of the intubation procedure, typically within 48 hours.

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Identification of Novel Predictors of Difficult Airways
Time Frame: Data analysis will be conducted after completion of all participant procedures, typically within 2 years of the last participant's assessment.
To identify and characterize new predictive parameters that contribute to the AI system's overall ability to determine the likelihood of a difficult airway.
Data analysis will be conducted after completion of all participant procedures, typically within 2 years of the last participant's assessment.

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Investigators

  • Principal Investigator: Will Ne-Hooi Loh, National University Hospital, Singapore

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

May 17, 2022

Primary Completion (Actual)

January 24, 2025

Study Completion (Estimated)

December 1, 2026

Study Registration Dates

First Submitted

December 21, 2025

First Submitted That Met QC Criteria

February 8, 2026

First Posted (Actual)

February 13, 2026

Study Record Updates

Last Update Posted (Actual)

February 13, 2026

Last Update Submitted That Met QC Criteria

February 8, 2026

Last Verified

December 1, 2025

More Information

Terms related to this study

Other Study ID Numbers

  • 2021/00908

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

NO

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Anaesthesia

Clinical Trials on AI-Assisted Preoperative Airway Risk Assessment

Subscribe